MedTrace Logo

Topcon 3D OCT-1 Maestro Reference Database Study II

NCT02447120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 504

Last updated 2022-06-08

No results posted yet for this study

Summary

The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro based on the percentile points for 1%, 5%, 95%, and 99%.

Conditions

  • Healthy

Interventions

DEVICE

3D OCT-1 Maestro

OCT machines used for diagnostic purposes

Sponsors & Collaborators

  • Topcon Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Charles Reisman, MS · Topcon Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02447120 on ClinicalTrials.gov